Skip Nav Destination
Abstract 387: Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment response
Cancer Res (2021) 81 (13_Supplement): 387.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy
- Yeonggyeong Park
- Min Jeong Kim
- Yoonhee Choi
- Na Hyun Kim
- Leeseul Kim
- Seung Pyo Daniel Hong
- Hyung-Gyo Cho
- Emma Yu
- Young Kwang Chae
Journal for ImmunoTherapy of Cancer (2022) 10 (3): e003566.